EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): S$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.17. In 2024 the company made an earnings per share (EPS) of S$0.18 an increase over its 2023 EPS that were of S$0.12.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.17	-2.61%
2024	S$0.18	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.20	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.09981	31.21%
2016	S$0.07607	11.46%
2015	S$0.06825	36.27%
2014	S$0.05008	19.77%
2013	S$0.04181	18.05%
2012	S$0.03542	23.9%
2011	S$0.02859	26.9%
2010	S$0.02253	12.37%
2009	S$0.02005	56.6%
2008	S$0.01280	9.18%
2007	S$0.01173	114.48%
2006	S$0.005467	64.83%
2005	S$0.003317	35.55%
2004	S$0.002447	29.73%
2003	S$0.001886	19.86%
2002	S$0.001574	-2.71%
2001	S$0.001618	1.02%
2000	S$0.001601

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions